University of Cincinnati researchers are presenting abstracts at the European St...
Massachusetts-based biotech Moderna has shared results from its early clinical t...
The $300 million series A raised by ReNAgade Therapeutics has been surpassed by ...
The review of a highly anticipated gene therapy for Duchenne muscular dystrophy ...
Novo Nordisk has announced that an oral form of semaglutide, the medication mark...
M&A activity for pharma CMOs reached a peak in 2021, with 2022 seeing a slight d...
Rinvoq is expected to have a rapid uptake in the CD market by healthcare provide...
VANFLYTA was first approved as a monotherapy in the relapsed/refractory setting.
The NDA included data from the Phase III FRESCO-2 and FRESCO trials conducted in...
A few weeks after Covid-19 emergency declaration ended, the FDA has approved Pax...
The immune-oncology market is forecasted to grow to over $150 billion by 2028, b...
The larger facility is expected to help Touchlight supply plasmid DNA to meet th...
Insulin delivery devices are proliferating despite equitable insulin access bein...
As US drug prices increase, consumers are turning to illegal online pharmacies t...
Patients with DEB have extremely fragile skin that blisters and tears with minor...
The U.K. government on Thursday unveiled an $800 million package to bolster the ...
